- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04486235
A Randomized, Controlled Pilot Study of a Patient-Initiated Approach to Increasing Weight Communication in Primary Care
April 13, 2021 updated by: Drexel University
This study tests the feasibility, acceptability, and preliminary efficacy of using a brief pamphlet in the primary care waiting room focused on promoting patient-initiated weight-related discussions in primary care appointments.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Obesity is a chronic and complex disease that many national and professional organizations recommend be discussed frequently in primary care.
However, rates of weight-related communication in primary care are suboptimal.
When patients and physicians communicate about weight (defined as usage of any the 5As-ask, assess, advise, agree, and/or assist-in a weight-related conversation), patients are more likely to improve dietary habits, demonstrate more motivation for health behavior change, attempt weight loss treatment, and lose more weight as compared to patients who do not engage in weight-related communication with their physicians.
Interventions have attempted to increase the rates of weight-related communication in primary care.
However, they have focused solely on physicians and have only yielded modest efficacy.
Intervention with patients on proposed patient-related barriers may be key to improving the rate of weight-related communication in primary care.
The waiting room prior to appointments is an underutilized intervention setting.
Prior waiting room interventions have shown promising results for increasing health communication between patients and physicians.
However, no prior study has focused on weight-related communication.
Thus, this study aims to test the feasibility, acceptability, and preliminary efficacy of an experiential pamphlet delivered in the waiting room targeting patient-related barriers to weight communication.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19127
- Drexel University Family Medicine Office
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Present for an appointment at the Family Medicine Office
- Indicate that they can speak and read English
- Indicate that their Shape is > or = 5 on measure (Stunkard, Sørensen, & Schulsinger, 1983)
- Indicate that they are 18 years or older
Exclusion Criteria:
- Indicate that they are Pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Receive experiential pamphlet
|
An experiential pamphlet including brief assessment questions and recommended questions for the participant to ask their physician based on their responses.
Areas covered in the pamphlet include patients' knowledge of weight status and implications of weight, confidence in physicians' abilities to treat weight, stage of change for weight-related behaviors, and comfort in discussing their weight.
|
|
No Intervention: Control
No materials, usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Acceptability Questionnaire
Time Frame: Immediately after appointment (Same day as intervention delivery)
|
Intervention participants reported acceptability, as measured by the Treatment Acceptability Questionnaire (Hunsley, 1992).
This is a 6-item scale that asks the participant to rate several metrics of acceptability with Likert scale responses (individual items range 1-7, one item is reverse scored).
A higher score indicates greater acceptability, a score of 21 is the benchmark for acceptability.
Overall range of 6-42.
|
Immediately after appointment (Same day as intervention delivery)
|
|
Feasibility of Recruitment From Primary Care Waiting Room and Intervention Delivery
Time Frame: When study staff is recruiting in the office during the data collection period, approx. 20 days over 6 months
|
Study flow will be tracked by study staff and compared to pre-determined benchmarks. 1) Percentage of patients who indicate verbal consent for screening (benchmark >70%), 2) percentage of eligible participants after screening (benchmark >50%), 3) percentage of participants who refuse to participate because of focus on weight (benchmark <20%), 4)percentage of participants who complete the experiential pamphlet (benchmark >80%).
|
When study staff is recruiting in the office during the data collection period, approx. 20 days over 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
If Weight Was Spoken About in the Appointment
Time Frame: Immediately after appointment (Same day as intervention delivery)
|
Participants respond to Yes/No questions about content of their appointment
|
Immediately after appointment (Same day as intervention delivery)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jocelyn Remmert, MS, Drexel University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 9, 2019
Primary Completion (Actual)
September 1, 2020
Study Completion (Actual)
November 1, 2020
Study Registration Dates
First Submitted
April 25, 2019
First Submitted That Met QC Criteria
July 23, 2020
First Posted (Actual)
July 24, 2020
Study Record Updates
Last Update Posted (Actual)
May 6, 2021
Last Update Submitted That Met QC Criteria
April 13, 2021
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1812006829
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Brief waiting room pamphlet
-
The University of Hong KongCompletedSmoking CessationHong Kong
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
-
Hadassah Medical OrganizationCompleted
-
Karadeniz Technical UniversityActive, not recruitingDental AnxietyTurkey (Türkiye)
-
Queen's UniversityUnknownDepression Anxiety DisorderCanada
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
Massachusetts General HospitalWithdrawn
-
Namik Kemal UniversityEnrolling by invitation
-
Fundación para la Formación e Investigación de...University of SalamancaNot yet recruitingHypertension | Pregnancy Induced Hypertension
-
Ada Health GmbHMuhimbili University of Health and Allied SciencesActive, not recruitingNeurological Conditions | Mental Health Conditions | Abdominal Pain/Gastrointestinal Issues | Lower Respiratory System Conditions | Upper Respiratory System Conditions | Ophthalmology Conditions | Orthopedic Conditions | Cardiovascular System Conditions | Genitourinary System Conditions | ENT Conditions | Dermatology Conditions and other conditionsTanzania